Bradley R. Corr

Also affiliated with University of Colorado Health, University of Colorado Cancer Center, University of Colorado Denver

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.208Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.006

Top 65%

0.208DataRank

Top 65%3 citations

Angeles Alvarez Secord, Steven G. Friedman, Erinn M. Hade, Carson Smitherman, Nikita Bisht +14 more

Papers

Driven by 11 papers — median percentile 35. Top paper: “A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer”.

A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.008

N/A

0.208DataRank · unranked

3 citations

Ashley Haggerty, Stefan M. Gysler, Sarah E. Taylor, Kian Behbakht, Jill Alldredge +10 more

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.006

Top 65%

0.208DataRank

Top 65%3 citations

Angeles Alvarez Secord, Steven G. Friedman, Erinn M. Hade, Carson Smitherman, Nikita Bisht +14 more

Surgical window-of-opportunity study of megestrol acetate compared with megestrol acetate and metformin for endometrial intraepithelial neoplasia.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5601

N/A

0DataRank · unranked

0 citations

Allison Saiz, B.J. Rimel, Bradley R. Corr, Angeles Alvarez Secord, Leslie H. Clark +10 more

WNT4 regulates cellular metabolism via intracellular activity at the mitochondria in breast and gynecologic cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.15.499747

N/A

0DataRank · unranked

0 citations

Madeleine T. Shackleford, Fabian R. Villagómez, Shaymaa Bahnassy, Steffi Oesterreich, Junxiao Hu +8 more

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

Cancers(2023)10.3390/cancers16010091

N/A

0DataRank · unranked

11 citations

Jodi Kagihara, Bradley R. Corr, S. Lindsey Davis, Christopher H. Lieu, Sunnie S. Kim +14 more

WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0275

N/A

0DataRank · unranked

10 citations

Madeleine T. Shackleford, Sydney K. Robinson, Fabian R. Villagómez, Shaymaa Bahnassy, Steffi Oesterreich +9 more

Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1 -mutated endometrial cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.04.535570

N/A

0DataRank · unranked

6 citations

Marisa R. Moroney, Elizabeth R. Woodruff, Zachary L. Watson, Kimberly R. Jordan, Thomas Danhorn +4 more

Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0513

N/A

0DataRank · unranked

26 citations

Jessica L. Floyd, Li‐Wei Kuo, Miriam D. Post, Mike Bickerdike, Kathleen O’Neill +8 more

Wnt Signaling in Gynecologic Malignancies

International Journal of Molecular Sciences(2020)10.3390/ijms21124272

N/A

0DataRank · unranked

68 citations

Elizabeth R. Woodruff, Bradley R. Corr, Benjamin G. Bitler, Marisa R. Moroney, Alexandra McMellen

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

Frontiers in Oncology(2025)10.3389/fonc.2025.1546500

N/A

0DataRank · unranked

0 citations

Sama L. Kareem, Bradley R. Corr, Christopher H. Lieu, Breelyn A. Wilky, S. Lindsey Davis +9 more

A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5514

N/A

0DataRank · unranked

22 citations

Husam Alqaisi, David E. Cohn, Jing‐Yi Chern, Linda Duska, Andrea Jewell +15 more

Bradley R. Corr

Indexed papers

Top data-sharing exemplar

Papers